Top of the morning to you. Another pleasant day is unfolding here on the Pharmalot corporate campus, where the foliage is blossoming, the official mascots are keeping the neighbors at bay and the short people are bracing for another round of learning at the local schoolhouses. Meanwhile, we are brewing a cup of stimulation - a fresh jolt is always welcome, as you know. Feel free to join us. And while you do, here are some tidbits to help you along. Have a great day and stay in touch...
EU To Rule On Safety Of Novartis Gilenya Pill For MS (MarketWatch)
Mylan To Create 500 Jobs In Ireland (The Journal)
Bristol-Myers Expands Hep C Pact With J&J And Medivir (Bloomberg News)
Pfizer May Choose A Buyer For Baby Food Biz Next Week (Bloomberg News)
Prescription Spending Growth Slowed Last Year (Associated Press)
Abbott Reports Positive Data For Parkinson's Gel (Dow Jones)
Viagra Patent Faces Challenge In Canadian Court (Montreal Gazette)
UK's NICE Rejects Avastin For Metastatic Breast Cancer (Dow Jones)
CSL And Hospira Recall Drugs Over Contamination (InPharma Technologist)
Valeant Pharma Relies On M&A For R&D (Wall Street Journal)
Piramal Buys Bayer Imaging Portfolio Business (Hindustan Times)
NeurogesX Seeks Partners For Its Pain Drug (Reuters)
EDITOR'S NOTE: Please check this post for updates throughout the day
tea kettle thx to mirahartford on flickr